DCT | Dopachrome tautomerase | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
HOXB13 | Homeobox B13 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
FABP4 | Fatty acid binding protein 4, adipocyte | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
CXorf67 | Chromosome X open reading frame 67 | Predicted intracellular proteins
| | | | | Group enriched |
NPY | Neuropeptide Y | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
KLHL41 | Kelch-like family member 41 | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
KRT13 | Keratin 13 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
ASGR2 | Asialoglycoprotein receptor 2 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
DNM1 | Dynamin 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
IGF2BP1 | Insulin-like growth factor 2 mRNA binding protein 1 | Predicted intracellular proteins
| | | | | Group enriched |
CDH15 | Cadherin 15, type 1, M-cadherin (myotubule) | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
SV2A | Synaptic vesicle glycoprotein 2A | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
AFP | Alpha-fetoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AKR1B1 | Aldo-keto reductase family 1, member B1 (aldose reductase) | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
AMPH | Amphiphysin | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enriched |
MAP2 | Microtubule-associated protein 2 | FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
S100B | S100 calcium binding protein B | Cancer-related genes Candidate cardiovascular disease genes Predicted intracellular proteins
| | | | | Group enriched |
VIL1 | Villin 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
AHNAK2 | AHNAK nucleoprotein 2 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enriched |
BIN1 | Bridging integrator 1 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enriched |
CSTA | Cystatin A (stefin A) | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
DSP | Desmoplakin | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
FABP5 | Fatty acid binding protein 5 (psoriasis-associated) | Cancer-related genes Plasma proteins Predicted intracellular proteins Transporters
| | | | | Tissue enriched |
SIX1 | SIX homeobox 1 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
SOAT1 | Sterol O-acyltransferase 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
CDX2 | Caudal type homeobox 2 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
FHL2 | Four and a half LIM domains 2 | Predicted intracellular proteins
| | | | | Group enriched |
KHDRBS3 | KH domain containing, RNA binding, signal transduction associated 3 | Predicted intracellular proteins
| | | | | Group enriched |
MRGBP | MRG/MORF4L binding protein | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
OAT | Ornithine aminotransferase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
RAB11FIP3 | RAB11 family interacting protein 3 (class II) | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enriched |
AK1 | Adenylate kinase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ASS1 | Argininosuccinate synthase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
BAG5 | BCL2-associated athanogene 5 | Predicted intracellular proteins
| | | | | Tissue enriched |
FASN | Fatty acid synthase | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
JUP | Junction plakoglobin | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
LYAR | Ly1 antibody reactive | Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
PEG10 | Paternally expressed 10 | Predicted intracellular proteins
| | | | | Group enriched |
PLCB3 | Phospholipase C, beta 3 (phosphatidylinositol-specific) | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
SATB2 | SATB homeobox 2 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
UCHL1 | Ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
ZNF185 | Zinc finger protein 185 (LIM domain) | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AK4 | Adenylate kinase 4 | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ALDH1A3 | Aldehyde dehydrogenase 1 family, member A3 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
ANLN | Anillin, actin binding protein | Predicted intracellular proteins
| | | | | Tissue enhanced |
ARID3A | AT rich interactive domain 3A (BRIGHT-like) | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ARID3B | AT rich interactive domain 3B (BRIGHT-like) | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
BAG2 | BCL2-associated athanogene 2 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |